核受体
过氧化物酶体增殖物激活受体
转录因子
受体
癌症研究
配体(生物化学)
生物
内科学
化学
药理学
细胞生物学
生物化学
医学
基因
作者
Linjing Shu,Renhuan Huang,Songtao Wu,Zhaozhao Chen,Ke Sun,Yan Jiang,Xiaoxiao Cai
标识
DOI:10.2174/1574888x10666150630111618
摘要
Peroxisome proliferator-activated receptor γ (PPARγ) is a versatile member of the ligandactivated nuclear hormone receptor superfamily of transcription factors, with expression in several different cell lines, especially in the digestive system. After being activated by its ligand, PPARγ can suppress the growth of oral, esophageal, gastric, colorectal, liver, biliary, and pancreatic tumor cells, suggesting that PPARγ ligand is a potential anticancer agent in PPARγ-expressing tumors. This review highlights key advances in understanding the effects of PPARγ ligands in the treatment of tumors in the digestive system. Keywords: Antitumor, chemoprevention, digestive system, peroxisome proliferator-activated receptor γ, thiazolidinediones (TZDs), tumor cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI